خط مشی دسترسیدرباره ما
ثبت نامثبت نام
راهنماراهنما
فارسی
ورودورود
صفحه اصلیصفحه اصلی
جستجوی مدارک
تمام متن
منابع دیجیتالی
رکورد قبلیرکورد بعدی
library name : انستیتو تغذیه دانشگاه علوم پزشکی شهید بهشتی
Material Type : Latin Articles
Language of Document : English
Record Number : 61818
Doc. No : 472A
Main Entry : PEYGHAMBARI M.M
Title & Author : EVALUATION OF STATINS IN DECREASING THE EARLY MORTALITY AND MORBIDITY OF ACUTE CORONARY SYNDROME [Article]; ZAFARAN LOU N.,ZAHEDI L.
Title : IRANIAN HEART JOURNAL (IHJ)
Volume Number : , Vol.8 ؛ No.2
Date : , (2007)
page : : 6 - 15
Abstract : Background- Lipid-lowering therapy with statin reduces the risk of cardiovascular events in acute coronary syndrome )ACS(. Preclinical and clinical evidence also indicates that in addition to its lipid-lowering effects, statin may reduce inflammation improve endothelial function and increase plaque stability.Methods- We enrolled 220 patients who had been hospitalized for an acute coronary syndrome )unstable angina, non-ST elevation MI( within the preceding 30 days and compared 20 mg of simvastatin daily )group B( with patients not receiving that )group A(. The primary end point was a composite of deaths, myocardial infarction, documented unstable angina requiring re-hospitalization, and urgent revascularization )performed at least 30 days after randomization(.Follow-up lasted for one month. Results- Median LDL cholesterol level achieved during treatment was similar; 90 mg/dl in group B and 87.1 mg/dl in group A )p> 0.05(. Chi-square and t-test estimates of the rate of the documented unstable angina requiring hospitalization were 26.4 percent in group Band 31 percent in group A )odds ratio= 4.5; 95percent CI= 2.4-6; P= 0.01(. Revascularization and early angiography was 20.9 percent in group Band 48.2 percent in group A )odds ratio= 3.5; 95percent CI= 1.9-6.3; P< 0.001(. Group B had a lower risk of myocardial infarction after admission due to acute coronary syndrome )odds ratio= 4; 95percent CI= 1.1-6; P<0.001(, reflecting a reduction in mortality )0.9percent in group Band 2.7percent in group A(, but this difference was not significant )P= 0.6(, at least partially because' of the relatively small number of mortalities in this study )1.8percent(.Conclusion- Early use of simvastatin in ACS appears to decrease risk for cardiovascular events. We believe statin therapy should be initiated early )at the latest before hospital discharge( in all patients who have been hospitalized for acute coronary syndrome.
Descriptor : ACUTE CORONARY SYNDROME
Descriptor : BLOOD LIPIDS
Descriptor : STATINS
Descriptor : MORTALITY
Descriptor : MORBIDITY
Added Entry : MADANI M
: SHAH MOHAMADI MOUSAVI A
 
 
 
(در صورت عدم وضوح تصویر اینجا را کلیک نمایید)